The vaccination of the general public was given the green light by the Chinese authorities just a few weeks ago at the end of December 2020. The first vaccine to be approved has been developed by the state-owned Sinopharm.
A second vaccine, CoronaVac, developed by Sinovac, a Beijing-based biopharmaceutical company has also been given approval, albeit only for emergency use amongst high-risk recipients.
According to the Chinese-based news source Sina, over 600,000 people have been vaccinated against COVID-19 in Shanghai to-date.
China reported the first death from COVID-19 since May 2020, with the fatality occurring in Hebei Province, which surrounds Beijing, where new lockdowns were recently imposed amid a new outbreak of the virus.